Ubs Asset Management Americas Inc Deciphera Pharmaceuticals, Inc. Transaction History

Ubs Asset Management Americas Inc

$277 Billion
Q1 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Deciphera Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 398,540 shares of DCPH stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

398,540

Previous 400,044 0.38%

Holding current value

Previous $6.45 Million 2.84%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $20,424 - $26,109	-1,504 Reduced 0.38%	398,540 $6.27 Million
Q4 2023 Feb 14, 2024	SELL	$10.11 - $16.54 $28,853 - $47,205	-2,854 Reduced 0.71%	400,044 $6.45 Million
Q3 2023 Nov 13, 2023	SELL	$12.46 - $15.48 $167,063 - $207,555	-13,408 Reduced 3.22%	402,898 $5.12 Million
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $5.42 Million - $8.41 Million	380,355 Added 1057.98%	416,306 $6.43 Million
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $247,787 - $317,701	-16,686 Reduced 31.7%	35,951 $589,000

Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $26,319 - $43,008	2,126 Added 4.21%	52,637 $973,000
Q2 2022 Aug 12, 2022	BUY	$9.11 - $13.98 $53,175 - $81,601	5,837 Added 13.07%	50,511 $664,000
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $2.41 Million - $11.6 Million	-312,949 Reduced 87.51%	44,674 $436,000
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $935,493 - $1.31 Million	-35,355 Reduced 9.0%	357,623 $12.2 Million
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $3.51 Million - $5.14 Million	107,177 Added 37.5%	392,978 $14.4 Million
Q1 2021 May 14, 2021	SELL	$40.39 - $56.73 $4.14 Million - $5.81 Million	-102,410 Reduced 26.38%	285,801 $12.8 Million
Q4 2020 Mar 01, 2021	BUY	$51.77 - $66.18 $5.43 Million - $6.94 Million	104,822 Added 36.99%	388,211 $22.2 Million
Q3 2020 Nov 13, 2020	BUY	$43.8 - $58.16 $555,208 - $737,236	12,676 Added 4.68%	283,389 $14.5 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $470,127 - $825,165	-12,689 Reduced 4.48%	270,713 $16.2 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $953,141 - $1.97 Million	-28,342 Reduced 9.09%	283,402 $11.7 Million
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $2.69 Million - $5.93 Million	84,745 Added 37.33%	311,744 $19.4 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $4.53 Million - $8.82 Million	226,999 New	226,999 $7.7 Million

Others Institutions Holding DCPH

# of Institutions

178

Shares Held

59.6M

Call Options Held

5.3K

Put Options Held

27.6K

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Deciphera Pharmaceuticals, Inc. Transaction History